Haematologica (May 2020)
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
- Zuzana Chyra,
- Tereza Sevcikova,
- Petr Vojta,
- Janka Puterova,
- Lucie Brozova,
- Katerina Growkova,
- Jana Filipova,
- Martina Zatopkova,
- Sebastian Grosicki,
- Agnieszka Barchnicka,
- Wieslaw Wiktor Jedrzejczak,
- Anna Waszczuk-Gajda,
- Alexandra Jungova,
- Aneta Mikulasova,
- Marian Hajduch,
- Martin Mokrejs,
- Ludek Pour,
- Martin Stork,
- Lubica Harvanova,
- Martin Mistrik,
- Gabor Mikala,
- Pawel Robak,
- Anna Czyz,
- Jakub Debski,
- Lidia Usnarska-Zubkiewicz,
- Artur Jurczyszyn,
- Lukas Stejskal,
- Gareth Morgan,
- Fedor Kryukov,
- Eva Budinska,
- Michal Simicek,
- Tomas Jelinek,
- Matous Hrdinka,
- Roman Hajek
Affiliations
- Zuzana Chyra
- Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;
- Tereza Sevcikova
- Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic;
- Petr Vojta
- Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic;
- Janka Puterova
- Brno University of Technology, Centre of Excellence IT4Innovations, Brno, Czech Republic;
- Lucie Brozova
- Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic;
- Katerina Growkova
- Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic;
- Jana Filipova
- Department of Biology and Ecology, Faculty of Science, University of Ostrava, Czech Republic;
- Martina Zatopkova
- Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic;
- Sebastian Grosicki
- Dept. of Hematology and Cancer Prevention, Medical University of Silesia in Katowice, Poland;
- Agnieszka Barchnicka
- Dept. of Hematology and Cancer Prevention, Medical University of Silesia in Katowice, Poland;
- Wieslaw Wiktor Jedrzejczak
- Department of Haematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland;
- Anna Waszczuk-Gajda
- Department of Haematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland;
- Alexandra Jungova
- Charles University Hospital Pilsen, Czech Republic;
- Aneta Mikulasova
- Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom;
- Marian Hajduch
- Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic;
- Martin Mokrejs
- IT4Innovations, VSB, Technical University of Ostrava, Ostrava, Czech Republic;
- Ludek Pour
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Czech Republic;
- Martin Stork
- Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Czech Republic;
- Lubica Harvanova
- Department of Haematology and Transfusiology, University Hospital Bratislava, Slovakia;
- Martin Mistrik
- Department of Haematology and Transfusiology, University Hospital Bratislava, Slovakia;
- Gabor Mikala
- Dept. of Haematology & Stem Cell Transplantation, South Pest Central Hospital, Budapest, Hungary;
- Pawel Robak
- Department of Haematology, Medical University of Lodz, Copernicus Memorial Hospital, Łódź, Poland;
- Anna Czyz
- Dept. and Clinic of Haematology, Blood Neoplasms, Wroclaw Medical University, Poland;
- Jakub Debski
- Dept. and Clinic of Haematology, Blood Neoplasms, Wroclaw Medical University, Poland;
- Lidia Usnarska-Zubkiewicz
- Dept. and Clinic of Haematology, Blood Neoplasms, Wroclaw Medical University, Poland;
- Artur Jurczyszyn
- Jagiellonian University Medical College, Cracow, Poland;
- Lukas Stejskal
- Silesian Hospital Opava, Opava, Czech Republic;
- Gareth Morgan
- Dpt. of Medicine, Multiple Myeloma Research Perlmutter Cancer Center, NYU School of Medicine, USA;
- Fedor Kryukov
- Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic;
- Eva Budinska
- RECETOX, Faculty of Science, Masaryk university in Brno, Brno, Czech Republic
- Michal Simicek
- Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic;
- Tomas Jelinek
- Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic;
- Matous Hrdinka
- Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic;
- Roman Hajek
- Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic;
- DOI
- https://doi.org/10.3324/haematol.2019.239756
- Journal volume & issue
-
Vol. 106,
no. 2
Abstract
No abstracts available.